acetylglucosamine has been researched along with Pulmonary Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Jin, S; Li, J; Liu, J; Luan, X; Tan, X; Tian, K; Wang, J; Wang, Z; Xu, X; Yin, S; Zhang, G; Zhang, N; Zhao, X | 1 |
1 other study(ies) available for acetylglucosamine and Pulmonary Fibrosis
| Article | Year |
|---|---|
N-Acetylglucosamine mitigates lung injury and pulmonary fibrosis induced by bleomycin.
Topics: Acetylglucosamine; Bleomycin; COVID-19; Humans; Lung Injury; Pulmonary Fibrosis | 2023 |